OverviewSuggest Edit

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec’s products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
TypePublic
HQReading, GB
Websiteconvatec.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Feb 2021)9,197
Job Openings396
Revenue (FY, 2018)£1.4 B(+4%)
Share Price (Nov 2021)£2.2
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at ConvaTec

Karim Bitar

Karim Bitar

Chief Executive Officer and Director
Frank Schulkes

Frank Schulkes

Chief Financial Officer and Director
David Shepherd

David Shepherd

President and Chief Operating Officer, Global Advanced Wound Care
Margaret Ewing

Margaret Ewing

Senior Independent Non-Executive Director
Mani Gopal

Mani Gopal

President and Chief Operating Officer, Global Ostomy Care
Rick Anderson

Rick Anderson

Independent Non-Executive Director
Show more

ConvaTec Office Locations

ConvaTec has offices in Reading, Flintshire, Rhymney, Bridgewater Township and in 54 other locations
Reading, GB (HQ)
3 Forbury Place, Forbury Estate, 23 Forbury Road
Flintshire, GB
Unit 20 First Avenue Deeside Industrial Park Deeside
Rhymney, GB
Units 1 & 2 Heads of the Valleys Industrial Estate
Melbourne, AU
Level 2, Building 5, Brandon Business Park, 530 Springvale Road, Brandon Park
Wien, AT
6 Schubertring
Fanipaĺ, BY
Zavodskaya str. 50
Show all (67)

ConvaTec Financials and Metrics

ConvaTec Revenue

ConvaTec's revenue was reported to be £1.4 b in FY, 2018
GBP

Revenue (FY, 2018)

1.4b

Gross profit (FY, 2018)

746.3m

Gross profit margin (FY, 2018), %

53.2%

Net income (FY, 2018)

169.8m

EBIT (FY, 2018)

205.1m

Market capitalization (10-Nov-2021)

4.4b

Closing stock price (10-Nov-2021)

2.2

Cash (31-Dec-2018)

241.9m

EV

5.4b
ConvaTec's current market capitalization is £4.4 b.
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.7b1.7b1.4b1.4b

Cost of goods sold

799.9m642.4m657.8m

Gross profit

850.5m709.9m746.3m

Gross profit Margin, %

52%52%53%
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Cash

273.0m264.1m221.7m241.9m

Accounts Receivable

223.8m233.7m196.5m188.2m

Inventories

228.9m247.5m218.0m232.4m

Current Assets

757.2m770.8m670.6m692.2m
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Cash From Operating Activities

100.3m74.9m235.0m269.8m

Cash From Investing Activities

(36.9m)(63.7m)(139.9m)(62.0m)

Cash From Financing Activities

(8.3m)4.5m(91.4m)(175.8m)

Net Change in Cash

55.1m15.7m3.6m32.0m
GBPFY, 2015

Financial Leverage

-17.3 x
Show all financial metrics

ConvaTec Operating Metrics

FY, 2016

Countries

100

Drugs in Development

60

Manufacturing Facilities

9

New Product Launches

13
Show all operating metrics

ConvaTec Revenue Breakdown

Embed Graph

ConvaTec revenue breakdown by business segment: 33.1% from Advanced Wound Care, 30.3% from Ostomy Care, 21.1% from Continence & Critical Care and 15.4% from Infusion Devices

ConvaTec Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

ConvaTec Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

ConvaTec Online and Social Media Presence

Embed Graph

ConvaTec News and Updates

ConvaTec Selects Veeva Vault CDMS for Biomarker Study in Wound Infections

PLEASANTON, Calif., Sept. 23, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that ConvaTec, a global medical products company providing therapies focused on the management of chronic conditions, has selected Veeva Vault CDMS to provide electronic data capture (EDC),...

ConvaTec Enhances Innovation Management with Anaqua

Anaqua’s AQX platform to help global medical products group protect and optimize its valuable IP portfolios Anaqua’s AQX platform to help global medical products group protect and optimize its valuable IP portfolios

Worldwide Burn Care Centers Industry to 2028 - Players Include Convatec Healthcare, Coloplast & Acelity Among Others

Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Burn Care Centers Market Share, Size, Trends, Industry Analysis Report, By Facility Type, By Treatment Type; By Severity; By Service Type; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering. The global…

ConvaTec awarded contract for Ostomy Products from Vizient, Inc.

BRIDGEWATER, N.J. , March 31, 2021 (GLOBE NEWSWIRE) -- ConvaTec, a global medical solutions company focused on therapies for the management of chronic conditions, has been awarded a contract for Ostomy products with Vizient, Inc.

Europe Biofilms Treatment Market Report 2020: Market is Expected to Reach US$ 833.61 Million in 2027 from US$ 454.60 Million in 2019 - Leading Players are Coloplast Group, MiMedx, ConvaTec

Dublin, March 31, 2021 (GLOBE NEWSWIRE) -- The "Europe Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Wound; End User; and Country" report has been added to ResearchAndMarkets.com's offering. Europe Biofilms Treatment Market is expected to reach US$ …

North America Biofilms Treatment Market 2020-2027 with Smith & Nephew, MiMedx, ConvaTec Group Dominating

Dublin, March 18, 2021 (GLOBE NEWSWIRE) -- The "North America Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Wound; End User; and Country" report has been added to ResearchAndMarkets.com's offering. North America Biofilms Treatment market is expected…
Show more

ConvaTec Frequently Asked Questions

  • Who are ConvaTec key executives?

    ConvaTec's key executives are Karim Bitar, Frank Schulkes and David Shepherd.

  • How many employees does ConvaTec have?

    ConvaTec has 9,197 employees.

  • What is ConvaTec revenue?

    Latest ConvaTec annual revenue is £1.4 b.

  • What is ConvaTec revenue per employee?

    Latest ConvaTec revenue per employee is £152.7 k.

  • Who are ConvaTec competitors?

    Competitors of ConvaTec include Integer Holdings, ForTec Medical and Mobile Instrument Service & Repair.

  • Where is ConvaTec headquarters?

    ConvaTec headquarters is located at 3 Forbury Place, Forbury Estate, 23 Forbury Road , Reading.

  • Where are ConvaTec offices?

    ConvaTec has offices in Reading, Flintshire, Rhymney, Bridgewater Township and in 54 other locations.

  • How many offices does ConvaTec have?

    ConvaTec has 67 offices.